IMCannabis
  • About Us
  • Our Strains & Oils
  • IMC Magazine
  • Investor Relations
    • Stock Information
    • About
    • Innovation and Technology
    • Presentations
    • Financials
    • Corporate Governance
    • Management
    • Press Releases
  • Contact Us
Select Page
IMC Applies to List its Common Shares on the NASDAQ Capital Market

IMC Applies to List its Common Shares on the NASDAQ Capital Market

by liel we | Oct 11, 2020 | Uncategorized

Toronto, Canada; Glil Yam, Israel – October 8, 2020 – IM Cannabis Corp. (the “Company” or “IMC”) (CSE:IMCC), a multi-country operator (“MCO”) in the medical cannabis sector with operations in Israel and across Europe, is pleased to announce that it has applied to list...
IMC Applies to List its Common Shares on the NASDAQ Capital Market

IM Cannabis Accelerates Sales in Germany, Reaching Adjusted EBITDA Profitability

by liel we | Oct 8, 2020 | Uncategorized

Shipments made to seven distribution partners in Germany German operations and growing sales by Focus Medical create inflection point to positive adjusted EBITDA profitability beginning in September 2020 IMC Netherlands has submitted its application to the Dutch...
IMC Applies to List its Common Shares on the NASDAQ Capital Market

Israeli Ministry of Health Opens International Export Market for Israeli Medical Cannabis Producers

by liel we | Oct 6, 2020 | Uncategorized

Israeli Ministry of Health announced that it will begin accepting applications for a medical cannabis export Pilot Program IMC well positioned to leverage German EU-GMP certified subsidiary under the export Pilot Program to distribute IMC-branded medical cannabis...
IMC Applies to List its Common Shares on the NASDAQ Capital Market

IM Cannabis Launches Sales of IMC-Branded Products in Germany, Adds to Pipeline of Purchase Agreements

by liel we | Sep 24, 2020 | Uncategorized

IMC has now completed shipments of its branded flower products to four of the Company’s ten distribution partners, marking IMC’s official brand launch in Germany Three additional purchase commitments executed with German distributors IMC now has binding purchase...
IMC Applies to List its Common Shares on the NASDAQ Capital Market

IM Cannabis Completes First Import into Germany, Further Strengthens Distribution Network

by liel we | Sep 16, 2020 | Uncategorized

First shipment received into Germany from EU-GMP supply partner, allowing the Company to begin fulfilling purchase commitments for IMC-branded products Adjupharm adds Cansativa, Ilios and Farmako to its distribution network, platform now includes ten distributors *...
IMC Applies to List its Common Shares on the NASDAQ Capital Market

IM Cannabis Reports 62% Increase in Consolidated Revenue and 54% Gross Margin in Q2 2020

by inbal | Aug 26, 2020 | Uncategorized

Consolidated revenue increased to $3.8 million in Q2 2020, from $2.3 million in the prior year, a 62% increase, and a 180% increase over Q1 2020 Gross margin before fair value impacts was 54% in Q2 2020 Q2 2020 milestones include: Six pharmacy sales agreements signed...
« Older Entries
  • Investors Overview
  • Stock Information
  • About
  • Innovation and Technology
  • Presentations
  • Financials
  • Corporate Governance
  • Management
  • Press Releases

[email protected]
+972 58 6683040 Whatsapp
1 416 467 5229 Canada
972 77 4442333 Israel
972 77 4442331 Fax

IMC
  • Stock Information
  • About
  • Innovation and Technology
  • Presentations
  • Financials
  • Corporate Governance
  • Management
  • Press Releases
  • Terms of Use
  • Privacy Policy

[email protected]
+972 58 6683040 Whatsapp
1 416 467 5229 Canada
972 77 4442333 Israel
972 77 4442331 Fax